Proteus TK2 to make proton therapy more affordable and accessible, say Philips, IBA
This article was originally published in Clinica
Executive Summary
A new turnkey proton therapy centre, jointly designed by Philips and proton systems developer IBA, could cost as little as a third of what healthcare providers would normally fork out to build a facility of this kind. By making it more affordable, the companies hope to pave the way for more proton therapy centres around the world, and to make this treatment more accessible to patients.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.